TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study

Ciarán P. Kelly, Mark S. Turner, Michael S. Boyne et al.|Gastroenterology|2021

Cited by 177